Im upbeat on the earnings_老虎社区_美港股上老虎

wishingstar
2021-06-24

Im upbeat on the earnings

Should You Buy Nike (NKE) Ahead of Earnings?

Investors are always looking for stocks that are poised to beat at earnings season and NIKE, Inc. NK

Should You Buy Nike (NKE) Ahead of Earnings?

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":121233468,"tweetId":"121233468","gmtCreate":1624464693654,"gmtModify":1631892796312,"author":{"id":3569924645980570,"idStr":"3569924645980570","authorId":3569924645980570,"authorIdStr":"3569924645980570","name":"wishingstar","avatar":"https://static.tigerbbs.com/33d7b13f080980449224c22c62e34653","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Im upbeat on the earnings</p></body></html>","htmlText":"<html><head></head><body><p>Im upbeat on the earnings</p></body></html>","text":"Im upbeat on the earnings","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/121233468","repostId":2145097908,"repostType":2,"repost":{"id":"2145097908","kind":"news","pubTimestamp":1624451652,"share":"https://www.laohu8.com/m/news/2145097908?lang=&edition=full","pubTime":"2021-06-23 20:34","market":"us","language":"en","title":"Should You Buy Nike (NKE) Ahead of Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2145097908","media":"Zacks","summary":"Investors are always looking for stocks that are poised to beat at earnings season and NIKE, Inc. NK","content":"<html><body><p>Investors are always looking for stocks that are poised to beat at earnings season and <strong>NIKE, Inc. </strong>NKE may be <a href=\"https://laohu8.com/S/AONE\">one</a> such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.<br/><br/>That is because Nike is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for NKE in this report.<br/><br/>In fact, the Most Accurate Estimate for the current quarter is currently at 54 cents per share for NKE, compared to a broader Zacks Consensus Estimate of 51 cents per share. This suggests that analysts have very recently bumped up their estimates for NKE, giving the stock a Zacks Earnings ESP of +5.23% heading into earnings season.</p>\n<div>\n<h3>NIKE, Inc. Price and EPS Surprise</h3>\n<img height=\"264\" src=\"https://s1.yimg.com/uu/api/res/1.2/j.HMX_clBjspmoyYPg8GGg--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/zacks.com/15d433e5b9fa5e8d213e5f0cd86714a1\" title=\"\" width=\"540\"/>\n<p>NIKE, Inc. price-eps-surprise | NIKE, Inc. Quote</p>\n</div>\n<h3>Why is this Important?</h3>\n<p>A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).<br/><br/>Given that NKE has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see <strong>the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.</strong><br/><br/>Clearly, recent earnings estimate revisions suggest that good things are ahead for Nike, and that a beat might be in the cards for the upcoming report.</p>\n<h3>Breakout Biotech Stocks with Triple-Digit Profit Potential</h3>\n<p>The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.<br/><br/>Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.<br/><br/><strong>See these 7 breakthrough stocks now&gt;&gt;</strong></p>\n<br/>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n<br/> \n<br/>\nNIKE, Inc. (NKE) : Free Stock Analysis Report\n<br/> \n<br/>\nTo read this article on Zacks.com click here.\n<br/> \n<br/>\nZacks Investment Research</body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should You Buy Nike (NKE) Ahead of Earnings?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould You Buy Nike (NKE) Ahead of Earnings?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-23 20:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/buy-nike-nke-ahead-earnings-123412238.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors are always looking for stocks that are poised to beat at earnings season and NIKE, Inc. NKE may be one such company. The firm has earnings coming up pretty soon, and events are shaping up ...</p>\n\n<a href=\"https://finance.yahoo.com/news/buy-nike-nke-ahead-earnings-123412238.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/Gml0h8hQ0THgy_JOhSbsHw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/2Q_KvEwm9Xm70ggru0uEfA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/f27535a474d3cc96595bb860fd37011d","relate_stocks":{"NKE":"耐克"},"source_url":"https://finance.yahoo.com/news/buy-nike-nke-ahead-earnings-123412238.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2145097908","content_text":"Investors are always looking for stocks that are poised to beat at earnings season and NIKE, Inc. NKE may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.That is because Nike is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for NKE in this report.In fact, the Most Accurate Estimate for the current quarter is currently at 54 cents per share for NKE, compared to a broader Zacks Consensus Estimate of 51 cents per share. This suggests that analysts have very recently bumped up their estimates for NKE, giving the stock a Zacks Earnings ESP of +5.23% heading into earnings season.\n\nNIKE, Inc. Price and EPS Surprise\n\nNIKE, Inc. price-eps-surprise | NIKE, Inc. Quote\n\nWhy is this Important?\nA positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).Given that NKE has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.Clearly, recent earnings estimate revisions suggest that good things are ahead for Nike, and that a beat might be in the cards for the upcoming report.\nBreakout Biotech Stocks with Triple-Digit Profit Potential\nThe biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. \nClick to get this free report\n \n\nNIKE, Inc. (NKE) : Free Stock Analysis Report\n \n\nTo read this article on Zacks.com click here.\n \n\nZacks Investment Research","news_type":1},"isVote":1,"tweetType":1,"viewCount":591,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":21,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}